OLANZAPINE GH IM (Generic Health Pty Ltd)
Product name
OLANZAPINE GH IM
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
124 (255 working days)
Active ingredients
olanzapine
Registration type
New generic medicine
Indication
Tradename is indicated for the rapid control of agitation and disturbed behaviours in patients with schizophrenia and related psychoses and in patients with acute mania associated with Bipolar 1 Disorder, when oral therapy is not appropriate.